Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Effect of Basrah bee honey and n-acetylcysteine against citalopram hepatotoxicity

Hassan Ali Laftaa1, Manal AbdulKhaliq Ibrahim2, Manal Nasser Al-Hayder2

1Department of Pharmacology and Toxicology, College of Pharmacy, University of Al-Muthana,; 2Department of Pharmacology and Toxicology, College of Pharmacy, University of Basra, Basra, Iraq.

For correspondence:-  Manal Al-Hayder   Email:

Received: 27 April 2026        Accepted: 18 July 2026        Published: 31 July 2026

Citation: Laftaa HA, Ibrahim MA, Al-Hayder MN. Effect of Basrah bee honey and n-acetylcysteine against citalopram hepatotoxicity. Trop J Pharm Res 2026; 25(7):995-1002 doi: https://dx.doi.org/10.4314/tjpr.v25i7.12

© 2026 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the effects of Basra bee honey and N-acetylcysteine as monotherapies and in combination against citalopram hepatotoxicity. Methods: A total of 30 healthy female albino Wistar rats were equally and randomly divided into five groups (n = 6). Group 1 received distilled water (control group), group 2 received citalopram (10 mg/kg/day), group 3 received Basra bee honey (150 mg/kg/day) and citalopram (10 mg/kg/day), group 4 received N-acetylcysteine (200 mg/kg/day) and citalopram (10 mg/kg/day), group 5 received Basra bee honey (150 mg/kg/day), N-acetylcysteine (200 mg/kg/day) and citalopram (10 mg/kg/day) via oral route. After 30 days, the rats were sacrificed under diethyl ether anaesthesia. Liver tissue homogenate and serum were taken, and tumour necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin-10 (IL-10), and glutathione (GSH) and malondialdehyde (MDA) were determined by enzyme-linked immunosorbent assay (ELISA). Results: Group 2 demonstrated significantly higher MDA, TNF-α, and IL-1β, and lower GSH and IL-10 compared to control (p < 0.05). Furthermore, group 5 showed significantly lower MDA, serum and tissue TNF-α, and IL-1β (p < 0.05) compared to control. Furthermore, GSH, serum and tissue IL-10 were significantly higher in group 5 compared to control (p < 0.05). Conclusion: Combination of Basra bee honey and N-acetylcysteine significantly reverses citalopram induced hepatotoxicity in rats.

Keywords: Basra bee honey, Citalopram, Inflammatory cytokines, N-acetylcysteine, Oxidative stress

Impact Factor
Thompson Reuters (ISI): 0.6 (2023)
H-5 index (Google Scholar): 49 (2023)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal: